F-star Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
F-star Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q3 2022.
  • F-star Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.45M, a 4.55% decline year-over-year.
  • F-star Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $5.66M, a 17.3% decline year-over-year.
  • F-star Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.9M, a 97.7% increase from 2020.
  • F-star Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $3.49M, a 30.7% increase from 2019.
  • F-star Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $2.67M, a 3.85% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $5.66M $1.45M -$69K -4.55% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $5.73M $1.42M -$444K -23.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.17M $1.45M -$726K -33.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.9M $1.34M +$54K +4.19% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $6.84M $1.52M +$321K +26.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $6.52M $1.86M +$1.39M +295% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $5.14M $2.18M +$1.65M +308% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.49M $1.29M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $1.19M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $471K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $534K -$438K -45.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $972K +$314K +47.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $658K +$158K +31.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q1 2017 $500K +$198K +65.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q1 2016 $302K +$189K +167% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q1 2015 $113K Jan 1, 2015 Mar 31, 2015 10-Q 2016-06-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.